Furthermore, epigenetic PTEN silencing mediated by its promoter methylation has been reported in 62% of metastatic melanoma serum samples, contributing to the constitutive activation of the AKT pathway and melanoma development [54]. The gene discussed is PTEN; the disease is melanoma.